GKL-006Allo
/ Beijing Gene Key Life Technology
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
July 16, 2026
GKL-006Allo Injection in Patients With Advanced Solid Tumors
(clinicaltrials.gov)
- P1 | N=27 | Not yet recruiting | Sponsor: Beijing Gene Key Life Technology Co., Ltd
New P1 trial • Oncology • Solid Tumor
1 to 1
Of
1
Go to page
1